Jeff Pavell

Jeff Pavell

Vermogen: 7 410 $ op 31-05-2026

59 jaar
Health Services
Health Technology
Consumer Services

Profiel

Dr. Jeff Pavell is an Independent Director at Hoth Therapeutics, Inc., an Independent Director at Silo Pharma, Inc., an Independent Director at FoxWayne Enterprises Acquisition Corp., an Associate Director-Pain Medicine at Center For Advanced Surgery LLC and a Chief-Rehabilitation Medicine at Englewood Hospital & Medical Center, Inc. He is on the Board of Directors at Hoth Therapeutics, Inc., Silo Pharma, Inc. and FoxWayne Enterprises Acquisition Corp.
Dr. Pavell was previously employed as a Partner by Patient Care Associates, Inc. and a Partner by Physical Medicine & Rehabilitation Center PA. He received his undergraduate degree from John Hopkins University Atlantic Basin Policy Institute and a doctorate degree from New York College of Osteopathic Medicine.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
26-05-2026 5.075 ( 0,03% ) 7 410 $ 31-05-2026

Actieve functies van Jeff Pavell

BedrijvenFunctieBegin
FOXWAYNE ENTERPRISES ACQUISITION CORP. Directeur/Bestuurslid 01-01-2021
SILO PHARMA, INC. Directeur/Bestuurslid 27-09-2022
ROCKET ONE INC. Directeur/Bestuurslid 07-12-2022
Corporate Officer/Principal 01-01-2000
Corporate Officer/Principal 01-04-2002

Eerdere bekende functies van Jeff Pavell

BedrijvenFunctieEinde
Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Jeff Pavell in detail bekijken

Opleiding van Jeff Pavell

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

28

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Health Services

Consumer Services

Consumer Services

Health Services

Health Technology

Finance

Health Services

Health Services

  1. Beurs
  2. Insiders
  3. Jeff Pavell